-
1
-
-
0031766447
-
Prospective study of serum gamma-glutamyltransferase and risk of NIDDM
-
Perry I.J., Wannamethee S.G., and Shaper A.G. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 21 (1998) 732-737
-
(1998)
Diabetes Care
, vol.21
, pp. 732-737
-
-
Perry, I.J.1
Wannamethee, S.G.2
Shaper, A.G.3
-
2
-
-
0037965955
-
Gamma-glutamyltransferase and diabetes - a 4 year follow-up study
-
Lee D.H., Ha M.H., Kim J.H., et al. Gamma-glutamyltransferase and diabetes - a 4 year follow-up study. Diabetologia 46 (2003) 359-364
-
(2003)
Diabetologia
, vol.46
, pp. 359-364
-
-
Lee, D.H.1
Ha, M.H.2
Kim, J.H.3
-
3
-
-
8344222696
-
The significance of serum gamma-glutamyltransferase in cardiovascular diseases
-
Pompella A., Emdin M., Passino C., and Paolicchi A. The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med 42 (2004) 1085-1091
-
(2004)
Clin Chem Lab Med
, vol.42
, pp. 1085-1091
-
-
Pompella, A.1
Emdin, M.2
Passino, C.3
Paolicchi, A.4
-
4
-
-
34249931199
-
A Strong interaction between serum {gamma}-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey
-
10.1373/clinchem.2006.079814 [published 3 May]
-
Lim J.S., Lee D.H., Park J.Y., Jin S.H., and Jacobs Jr. D.R. A Strong interaction between serum {gamma}-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey. Clin Chem (2007) 10.1373/clinchem.2006.079814 [published 3 May]
-
(2007)
Clin Chem
-
-
Lim, J.S.1
Lee, D.H.2
Park, J.Y.3
Jin, S.H.4
Jacobs Jr., D.R.5
-
5
-
-
0015348189
-
Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
-
Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
-
(1972)
Clin Chem
, vol.18
, pp. 499-502
-
-
Friedewald, W.T.1
Levy, R.I.2
Fredrickson, D.S.3
-
6
-
-
3042610458
-
Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications
-
Dobiasova M. Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications. Clin Chem 50 (2004) 1113-1115
-
(2004)
Clin Chem
, vol.50
, pp. 1113-1115
-
-
Dobiasova, M.1
-
7
-
-
0033613228
-
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology
-
Grundy S.M., Pasternak R., Greenland P., Smith Jr. S., and Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 100 (1999) 1481-1492
-
(1999)
Circulation
, vol.100
, pp. 1481-1492
-
-
Grundy, S.M.1
Pasternak, R.2
Greenland, P.3
Smith Jr., S.4
Fuster, V.5
-
8
-
-
0035897696
-
Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
9
-
-
21644468068
-
Gamma-glutamyl transferase and metabolic risk factors for cardiovascular disease
-
Sakuta H., Suzuki T., Yasuda H., and Ito T. Gamma-glutamyl transferase and metabolic risk factors for cardiovascular disease. Intern Med 44 (2005) 538-541
-
(2005)
Intern Med
, vol.44
, pp. 538-541
-
-
Sakuta, H.1
Suzuki, T.2
Yasuda, H.3
Ito, T.4
-
10
-
-
33847619687
-
Gamma glutamyl-transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study
-
Lee D.S., Evans J.C., Robins S.J., et al. Gamma glutamyl-transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27 (2007) 127-133
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 127-133
-
-
Lee, D.S.1
Evans, J.C.2
Robins, S.J.3
-
11
-
-
34547916668
-
The association between serum GGT level within normal range and risk factors of cardiovascular diseases
-
Lim J.S., Kim Y.J., Chun B.Y., Yang J.H., Lee D.H., and Kam S. The association between serum GGT level within normal range and risk factors of cardiovascular diseases. J Prev Med Pub Health 38 (2005) 101-106
-
(2005)
J Prev Med Pub Health
, vol.38
, pp. 101-106
-
-
Lim, J.S.1
Kim, Y.J.2
Chun, B.Y.3
Yang, J.H.4
Lee, D.H.5
Kam, S.6
-
12
-
-
24044518725
-
Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors
-
Kim D.J., Noh J.H., Cho N.H., et al. Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. Diabet Med 22 (2005) 1134-1140
-
(2005)
Diabet Med
, vol.22
, pp. 1134-1140
-
-
Kim, D.J.1
Noh, J.H.2
Cho, N.H.3
-
13
-
-
0037284703
-
Lipoprotein(a): an emerging cardiovascular risk factor
-
Lippi G., and Guidi G. Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci 40 (2003) 1-42
-
(2003)
Crit Rev Clin Lab Sci
, vol.40
, pp. 1-42
-
-
Lippi, G.1
Guidi, G.2
-
14
-
-
0028854118
-
Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus
-
DeMeester C.A., Bu X., Gray R.J., Lusis A.J., and Rotter J.I. Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus. Am J Hum Genet 56 (1995) 287-293
-
(1995)
Am J Hum Genet
, vol.56
, pp. 287-293
-
-
DeMeester, C.A.1
Bu, X.2
Gray, R.J.3
Lusis, A.J.4
Rotter, J.I.5
|